In order to further explore the expression of CD276 in GBM, TCGA and GEO databases were used to reveal that the mRNA expression level of CD276 in GBM was significantly higher compared with that in the normal control group (Supplementary Fig. S9A and B). The gene discussed is CD276; the disease is glioblastoma.